Publications

Found 42 results
Filters: Keyword is Animals  [Clear All Filters]
2013
Doores KJ, Huber M, Le KM, Wang S-K, Doyle-Cooper C, Cooper A, Pantophlet R, Wong C-H, Nemazee D, Burton DR.  2013.  2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.. J Virol. 87(4):2234-41.
Koff WC, Burton DR, Johnson PR, Walker BD, King CR, Nabel GJ, Ahmed R, Bhan MK, Plotkin SA.  2013.  Accelerating next-generation vaccine development for global disease prevention.. Science. 340(6136):1232910.
Gruell H, Bournazos S, Ravetch JV, Ploss A, Nussenzweig MC, Pietzsch J.  2013.  Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model.. J Virol. 87(15):8535-44.
Shingai M, Nishimura Y, Klein F, Mouquet H, Donau OK, Plishka R, Buckler-White A, Seaman M, Piatak M, Lifson JD et al..  2013.  Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia.. Nature. 503(7475):277-80.
Ota T, Doyle-Cooper C, Cooper AB, Doores KJ, Aoki-Ota M, Le K, Schief WR, Wyatt RT, Burton DR, Nemazee D.  2013.  B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidates.. J Immunol. 191(6):3179-85.
Tan WG, Jin H-T, West EE, Penaloza-MacMaster P, Wieland A, Zilliox MJ, McElrath JM, Barouch DH, Ahmed R.  2013.  Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors.. J Virol. 87(3):1359-72.
Iyer SS, Latner DR, Zilliox MJ, McCausland M, Akondy RS, Penaloza-MacMaster P, Hale JScott, Ye L, Mohammed A-U-R, Yamaguchi T et al..  2013.  Identification of novel markers for mouse CD4(+) T follicular helper cells.. Eur J Immunol. 43(12):3219-32.
Doyle-Cooper C, Hudson KE, Cooper AB, Ota T, Skog P, Dawson PE, Zwick MB, Schief WR, Burton DR, Nemazee D.  2013.  Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10.. J Immunol. 191(6):3186-91.
Shulman, iv Z, Gitlin AD, Targ S, Jankovic M, Pasqual G, Nussenzweig MC, Victora GD.  2013.  T follicular helper cell dynamics in germinal centers.. Science. 341(6146):673-7.
2012
Ota T, Doyle-Cooper C, Cooper AB, Huber M, Falkowska E, Doores KJ, Hangartner L, Le K, Sok D, Jardine J et al..  2012.  Anti-HIV B Cell lines as candidate vaccine biosensors.. J Immunol. 189(10):4816-24.
Feng Y, McKee K, Tran K, O'Dell S, Schmidt SD, Phogat A, Forsell MN, Karlsson Hedestam GB, Mascola JR, Wyatt RT.  2012.  Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site.. J Biol Chem. 287(8):5673-86.
Dosenovic P, Soldemo M, Scholz JL, O'Dell S, Grasset EK, Pelletier N, Karlsson MCI, Mascola JR, Wyatt RT, Cancro MP et al..  2012.  BLyS-mediated modulation of naive B cell subsets impacts HIV Env-induced antibody responses.. J Immunol. 188(12):6018-26.
Burton DR, Poignard P, Stanfield RL, Wilson IA.  2012.  Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses.. Science. 337(6091):183-6.
Ahmed FK, Clark BE, Burton DR, Pantophlet R.  2012.  An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site.. Vaccine. 30(5):922-30.
Moldt B, Rakasz EG, Schultz N, Chan-Hui P-Y, Swiderek K, Weisgrau KL, Piaskowski SM, Bergman Z, Watkins DI, Poignard P et al..  2012.  Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo.. Proc Natl Acad Sci U S A. 109(46):18921-5.
Barouch DH, Klasse P J, Dufour J, Veazey RS, Moore JP.  2012.  Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission.. Proc Natl Acad Sci U S A. 109(22):8694-8.
Chahroudi A, Bosinger SE, Vanderford TH, Paiardini M, Silvestri G.  2012.  Natural SIV hosts: showing AIDS the door.. Science. 335(6073):1188-93.
Montero M, Gulzar N, Klaric K-A, Donald JE, Lepik C, Wu S, Tsai S, Julien J-P, Hessell AJ, Wang S et al..  2012.  Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane.. J Virol. 86(6):2930-41.
Moldt B, Shibata-Koyama M, Rakasz EG, Schultz N, Kanda Y, Dunlop CD, Finstad SL, Jin C, Landucci G, Alpert MD et al..  2012.  A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques.. J Virol. 86(11):6189-96.

Pages